Literature DB >> 31704824

Aurora-A/NF-ĸB Signaling Is Associated With Radio-resistance in Human Lung Adenocarcinoma.

Jun-Bao Liu1, Liang Hu2, Zhijian Yang3, Y U Sun3,4, Robert M Hoffman3,4, Zhang Yi5.   

Abstract

BACKGROUND/AIM: This study aimed to discuss the effect and possible molecular mechanisms of Aurora-A/NF-ĸB signaling on the radiotherapy resistance of human docetaxel-resistant lung adenocarcinoma cells.
MATERIALS AND METHODS: The human lung adenocarcinoma SPC-A1 and SPC-A1/DTX cell lines were utilized in the present study. The MTT assay measured the sensitivity of cells to radiotherapy. The tumor-initiating ability of the cells was detected in vitro by cloning assays. Apoptosis was quantified by flow cytometry. Real-time quantitative PCR and western blotting were used to detect the mRNA and protein expression of the Aurora-A/NF-ĸB, respectively. Tumors transplanted subcutaneously into nude mice were used to test the effect of Aurora-A on the in vivo sensitivity of the tumors to radiotherapy.
RESULTS: The SPC-A1/DTX docetaxel-resistant lung adenocarcinoma cells were radio-resistant compared with the parental SPC-A1 cells. Up-regulated aurora-A was responsible for the in vitro radio-resistance of docetaxel-resistant SPC-A1/DTX cells. Nuclear transcription factor NF-ĸB was identified as a downstream target gene of Aurora-A in SPC-A1/DTX cells, and NF-ĸB also participated in the radio-resistance of SPC-A1/DTX cells regulated by Aurora-A.
CONCLUSION: The Aurora-A/NF-ĸB pathway is association with radio-resistance of human lung adenocarcinoma docetaxel-resistant cells. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Aurora-A; NF-ĸB; lung adenocarcinoma; radiotherapy

Mesh:

Substances:

Year:  2019        PMID: 31704824     DOI: 10.21873/anticanres.13804

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  SOD2- and NRF2-associated Gene Signature to Predict Radioresistance in Head and Neck Cancer.

Authors:  Joo Kyung Noh; Seon Rang Woo; Miyong Yun; Min Kyeong Lee; Moonkyoo Kong; Soonki Min; Su Il Kim; Young Chan Lee; Young-Gyu Eun; Seong-Gyu Ko
Journal:  Cancer Genomics Proteomics       Date:  2021 Sep-Oct       Impact factor: 4.069

2.  miR-126-5p enhances radiosensitivity of lung adenocarcinoma cells by inhibiting EZH2 via the KLF2/BIRC axis.

Authors:  Fushi Han; Dongdong Huang; Jinqian Meng; Jiapeng Chu; Meng Wang; Shuzhen Chen
Journal:  J Cell Mol Med       Date:  2022-03-24       Impact factor: 5.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.